Home    Back

Synb1618    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
240Phenylketonuria2

240. Phenylketonuria    [ 125 clinical trials,   95 drugs,   (DrugBank: 11 drugs),   1 drug target gene,   5 drug target pathways]
Searched query = "Phenylketonuria", "PKU", "Phenylalanine hydroxylase deficiency", "PAH deficiency", "Tetrahydrobiopterin deficiency", "BH4 deficiency", "BH4 reactive hyper pheemia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 125 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04534842
(ClinicalTrials.gov)		August 25, 202024/8/2020Efficacy and Safety of SYNB1618 in Adult Patients With PhenylketonuriaAn Open-label Study of the Efficacy and Safety of SYNB1618 in Patients With Phenylketonuria (SynPheny-1)PhenylketonuriaDrug: SYNB1618SynlogicNULLRecruiting18 YearsN/AAll12Phase 2United States
2NCT03516487
(ClinicalTrials.gov)		April 17, 201811/4/2018Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With PhenylketonuriaA Phase 1/2a, First-in-human, Oral Single and Multiple Dose-escalation, Randomized, Double-blinded, Placebo-controlled Study of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria to Evaluate Safety, Tolerability, Kinetics, and PharmacodynamicsPhenylketonuria;HealthyDrug: SYNB1618;Drug: PlaceboSynlogicNULLCompleted18 Years64 YearsAll70Phase 1;Phase 2United States